Back to Search
DRAKE CRAMER, DO
DO
Internal Medicine Physician
NPI: 1063972149IndividualAccepts Medicare
Education
OTHER
Class of 2019
Research & Publications (20)
Therapeutic potential of various beta-glucan sources in conjunction with anti-tumor monoclonal antibody in cancer therapy.
PMID 19106638·Cancer Biol Ther·2009
4-observational
Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium.
PMID 19127255·Br J Cancer·2009
4-observational
Use of nonsteroidal antiinflammatory agents and incidence of ovarian cancer in 2 large prospective cohorts.
PMID 19342401·Am J Epidemiol·2009
8-other
Novel anti-filamin-A antibody detects a secreted variant of filamin-A in plasma from patients with breast carcinoma and high-grade astrocytoma.
PMID 19594548·Cancer Sci·2009
7-preclinical
Serum and follicular fluid organochlorine concentrations among women undergoing assisted reproduction technologies.
PMID 19594949·Environ Health·2009
8-other
Flavonoid intake and ovarian cancer risk in a population-based case-control study.
PMID 19117058·Int J Cancer·2009
8-other
The epidemiology of ovarian granulosa cell tumors: a case-control study.
PMID 19664811·Gynecol Oncol·2009
8-other
A proteomic analysis of IVF follicular fluid in women <or=32 years old.
PMID 18980758·Fertil Steril·2009
8-other
Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancer.
PMID 19276375·Cancer Res·2009
8-other
Breast cancer susceptibility alleles and ovarian cancer risk in 2 study populations.
PMID 18973230·Int J Cancer·2009
8-other
Coffee intake, variants in genes involved in caffeine metabolism, and the risk of epithelial ovarian cancer.
PMID 18941913·Cancer Causes Control·2009
8-other
Point of failure as a predictor of in vitro fertilization treatment discontinuation.
PMID 18829010·Fertil Steril·2009
8-other
Polymorphisms in the vitamin D receptor and risk of ovarian cancer in four studies.
PMID 19223536·Cancer Res·2009
8-other
A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2.
PMID 19648919·Nat Genet·2009
8-other
Talc use, variants of the GSTM1, GSTT1, and NAT2 genes, and risk of epithelial ovarian cancer.
PMID 18768514·Cancer Epidemiol Biomarkers Prev·2008
4-observational
Activation of platelet-activating factor receptor and pleiotropic effects on tyrosine phospho-EGFR/Src/FAK/paxillin in ovarian cancer.
PMID 18632638·Cancer Res·2008
8-other
Consortium analysis of 7 candidate SNPs for ovarian cancer.
PMID 18431743·Int J Cancer·2008
4-observational
The "reverse capture" autoantibody microarray : an innovative approach to profiling the autoantibody response to tissue-derived native antigens.
PMID 18370319·Methods Mol Biol·2008
8-other
Mobilization of hematopoietic progenitor cells by yeast-derived beta-glucan requires activation of matrix metalloproteinase-9.
PMID 18339771·Stem Cells·2008
7-preclinical
Transient T cell depletion causes regression of melanoma metastases.
PMID 18334033·J Transl Med·2008
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 7320 216TH ST SW STE 200
EDMONDS, WA 98026 - Phone
- (425) 640-4900
Quick Facts
- NPI
- 1063972149
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 7
- Publications
- 20
Are you this provider?
Claim Your Profile